Journal article
Platelets, Frozen Plasma, and Cryoprecipitate: What is the Clinical Evidence for Their Use in the Neonatal Intensive Care Unit?
Seminars in perinatology, v 33(1), pp 66-74
2009
PMID: 19167583
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Transfusion of blood components such as platelets, frozen plasma, and cryoprecipitate is a common practice in the neonatal intensive care unit. Although it is intuitive that these components would be transfused in the context of bleeding, their use in neonatology has often been on a prophylactic basis. Due to a lack of consensus guidelines regarding indications for transfusion, however, the neonatologist is left to his/her opinion as to when to transfuse. This article seeks to review the available evidence regarding the use of platelets, frozen plasma, and cryoprecipitate in neonates, as well as the risks associated with the administration of these products.
Metrics
Details
- Title
- Platelets, Frozen Plasma, and Cryoprecipitate: What is the Clinical Evidence for Their Use in the Neonatal Intensive Care Unit?
- Creators
- Brandon S. Poterjoy - St. Christopher's Hospital for ChildrenCassandra D. Josephson - Children's Healthcare of AtlantaChristos D Katsetos
- Publication Details
- Seminars in perinatology, v 33(1), pp 66-74
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Web of Science ID
- WOS:000263088600009
- Scopus ID
- 2-s2.0-58249133376
- Other Identifier
- 991019353725804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Obstetrics & Gynecology
- Pediatrics